Chapter 085. Neoplasms of the Lung (Part 19) pdf

Chapter 085. Neoplasms of the Lung (Part 19) Further Readings Black C et al: Population screening for lung cancer using computed tomography: Is there evidence of clinical effectiveness? A systematic review of the literature. Thorax 62:131, 2007 [PMID: 17287305] Eberhardt W et al: Chemoradiation paradigm for the treatment of lung cancer. Nat Clin Pract Oncol 3:188, 2006 [PMID: 16596143] Hayes DN et al: Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independ ent patient cohorts. J Clin Oncol 24:5079, 2006 [PMID: 17075127] Sato M et al: Molecular genetics of lung cancer and translation to the clinic. J Thorac Oncol 2:327, 2007 [PMID: 17409807] Stinnett S et al: Role of chemotherapy for palliation in the lun g cancer patient. J Support Oncol 5:19, 2007 [PMID: 17265782] Subramanian J, Govindan R: Lung cancer in never smokers: A review. J Clin Oncol 25:561, 2007 [PMID: 17290066] Sun S et al: Of molecules and cancer stem cells: Novel therapeutic strategies for lung cancer. J Clin Invest 117, 2007 Wright G et al: Surgery for non- small cell lung cancer: Systematic review and meta- analysis of randomised controlled trials. Thorax 61:597, 2006 [PMID: 16449262] Bibliography Albain K et al: Phase III study of con current chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non- small cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309). Proc Am Soc Clin Oncol 23:7014, 2005 Alberts WM: Follow- up and surveillance of the patient with lung cancer: What do you do after surgery? Respirology 12:16, 2007 [PMID: 17207020] American College of Chest Physicians: Diagnosis and management of lung cancer: ACCP evidence-based guidelines. Chest 123:1S, 2003 Arriagada R et al: Cisplatin- based adjuvant chemotherapy in patients with completely resected non-small- cell lung cancer. N Engl J Med 350:351, 2004 [PMID: 14736927] Bach PB et al: Computed tomography screening and lung cancer outcomes. JAMA 297:953, 2007 [PMID: 17341709] Black WC, Baron JA: CT screening for lung cancer: Spiraling into confusion? JAMA 297:995, 2007 [PMID: 17341714] Cappuzzo F et al: Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. J Natl Cancer Inst 97:643, 2005 [PMID: 15870435] Devaraj A et al: PET/CT in non- small cell lung cancer staging: Promises and problems. Clin Radiol 62:97, 2007 [PMID: 17207691] Douillard JY et al: Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small- cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 7:719, 2006 [PMID: 16945766] Dy GK, Adjei AA: Novel tar gets for lung cancer therapy: Part I, Part II. J Clin Oncol 20:2881, 3016, 2002 Haiman CA et al: Ethnic and racial differences in the smoking- related risk of lung cancer. N Engl J Med 354:333, 2006 [PMID: 16436765] Hanna N et al: Randomized phase III t rial of pemetrexed versus docetaxel in patients with non-small- cell lung cancer previously treated with chemotherapy. J Clin Oncol 22:1589, 2004 [PMID: 15117980] Henschke CI et al: Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355:1763, 2006 [PMID: 17065637] Hotta K et al: Meta- analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small- cell lung cancer. J Clin Oncol 22:3852, 2004 [PMID: 15326195] International Adjuvant Lung Cancer Trial Collaborative Group: Cisplatin- based adjuvant chemotherapy in patients with completely resected non- small cell lung cancer. N Engl J Med 350:351, 2004 Jeong YJ et al: Solitary pulmonary nodules: Detection, characterization, and g uidance for further diagnostic workup and treatment. Am J Roentgenol 188:57, 2007 [PMID: 17179346] Johnson BE, Janne PA: Epidermal growth factor receptor mutations in patients with non- small cell lung cancer. Cancer Res 65:7525, 2005 [PMID: 16140912] K arnath B: Smoking cessation. Am J Med 112:399, 2002 [PMID: 11904115] Kato H et al: A randomized trial of adjuvant chemotherapy with uracil- tegafur for adenocarcinoma of the lung. N Engl J Med 350:1713, 2004 [PMID: 15102997] Keller S et al: A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small- cell lung cancer. N Engl J Med 343:1217, 2000 [PMID: 11071672] Kikuchi T, Carbone DP: Proteomics analysis in lung cancer: Challenges and opportunities. Respirology 12:22, 2007 [PMID: 17207021] Kobayashi S et al: EGFR mutation and resistance of non-small- cell lung cancer to gefitinib. N Engl J Med 352:786, 2005 [PMID: 15728811] Lynch TJ et al: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small- cell lung cancer to gefitinib. N Engl J Med 350:2129, 2004 [PMID: 15118073] Marcus PM et al: Extended lung cancer incidence follow- up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst 98:748, 2006 [PMID: 16757699] Minna JD et al: Focus on lung cancer. Cancer Cell 1:49, 2002 [PMID: 12086887] Mountain CF: Revisions in the international system for staging lung cancer. Chest 111:1710, 1997 [PMID: 9187198] ———, Dresler CM: Regional lymph node class ification for lung cancer staging. Chest 111:1718, 1997 Mulshine JL: Screening for lung cancer: In pursuit of pre- metastatic disease. Nat Rev Cancer 3:65, 2003 [PMID: 12509768] Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non- small cell lung cancer: A meta- analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311:899, 1996 Olaussen KA et al: DNA repair by ERCC1 in non-small- cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 355:983, 2006 [PMID: 16957145] Pao W et al: Targeting the epidermal growth factor receptor tyrosine kinase with gefitinib in non-small– cell lung cancer. Semin Cancer Biol 14:33, 2004 [PMID: 14757534] Peto R et al: Smoking, smoking cessation, and lung c ancer in the UK since 1950: Combination of national statistics with two case- control studies. BMJ 321:323, 2000 [PMID: 10926586] Pieterman RM et al: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346:92, 2002 Pignon J et al: Lung Adjuvant Cisplatin Evaluation (LACE): A pooled analysis of five randomized clinical trials including 4,584 patients. Proc Am Soc Clin Oncol 24:7008, 2006 Potti A et al. A genomic strategy to refine prognosis in early-stage non- small-cell lung cancer. N Engl J Med 355:570, 2006 [PMID: 16899777] Ramalingam S, Belani CP: Recent advances in targeted therapy for non- small cell lung cancer. Exp Opin Ther Targ 11:245, 2007 [PMID: 17227238] Sandler A et al: Paclitaxel-carboplatin alone or with bevacizumab for non- small-cell lung cancer. N Engl J Med 355:2542, 2006 [PMID: 17167137] Scagliotti GV: The ALPI Trial: The Italian/European experience with adjuvant chemotherapy in resectable non- small lung cancer. Clin Cancer Res 11:5011s, 2005 Schiller JH et al: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346:92, 2002 [PMID: 11784875] Sekido Y et al: Molecular genetics of lung cancer. Annu Rev Med 54:73, 2003 [PMID: 12471176] Shepherd FA et al. Erlotinib in previously treated non-small- cell lung cancer. N Engl J Med 353:123, 2005 [PMID: 16014882] Special issue dealing with all aspects of the diagnosis and treatment of small cell lung cancer. Semin Oncol 30:3, 2003 Spira A, Ettinger DS: Drug therapy: Multidisciplinary management of lung cancer. N Engl J Med 350:379, 2004 [PMID: 14736930] Strauss G et al: Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633. Proc Am Soc Clin Oncol 22:7019, 2004 Stroobants S et al: Value of FDG-PET in the management of non- small cell lung cancer. Eur J Radiol 45:49, 2003 [PMID: 12499064] Swensen SJ et al: CT screening for lung cancer: Five- year prospective experience. Radiology 235:259, 2005 [PMID: 15695622] Takano T et al: Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non- small-cell lung cancer. J Clin Oncol 23:6829, 2005 [PMID: 15998907] Tsao MS et al: Erlotinib in lung cancer— molecular and clinical predictors of outcome. N Engl J Med 353:133, 2005 [PMID: 16014883] Tyczynski JE et al: Lung cancer in Eur ope in 2000: Epidemiology, prevention, and early detection. Lancet Oncol 4:45, 2003 [PMID: 12517539] Unger M: A pause, progress, and reassessment in lung cancer screening. N Engl J Med 355:1822, 2006 [PMID: 17065645] [...]...Waller D et al: Chemotherapy for patients with non-small cell lung cancer: The surgical setting of the Big Lung Trial Eur J Cardiothorac Surg 26:173, 2004 [PMID: 15200998] Winton T et al: Vinorelbine plus cisplatin vs observation in resected nonsmall-cell lung cancer N Engl J Med 352:2589, 2005 [PMID: 15972865] Wistuba II: Genetics of preneoplasia: lessons from lung cancer Curr Mol Med 7:3, . Chapter 085. Neoplasms of the Lung (Part 19) Further Readings Black C et al: Population screening for lung cancer using computed tomography: Is there evidence of clinical effectiveness?. surveillance of the patient with lung cancer: What do you do after surgery? Respirology 12:16, 2007 [PMID: 17207020] American College of Chest Physicians: Diagnosis and management of lung cancer:. 355:1822, 2006 [PMID: 17065645] Waller D et al: Chemotherapy for patients with non- small cell lung cancer: The surgical setting of the Big Lung Trial. Eur J Cardiothorac Surg 26:173, 2004 [PMID: